Lea Veijola
Overview
Explore the profile of Lea Veijola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nyssen O, Bordin D, Tepes B, Perez-Aisa A, Vaira D, Caldas M, et al.
Gut
. 2020 Sep;
70(1):40-54.
PMID: 32958544
Objective: The best approach for management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care. Design: International multicentre prospective non-interventional registry...
2.
Lyra A, Hillila M, Huttunen T, Mannikko S, Taalikka M, Tennila J, et al.
World J Gastroenterol
. 2017 Jan;
22(48):10631-10642.
PMID: 28082816
Aim: To determine the effects of NCFM on irritable bowel syndrome (IBS) symptoms and quality of life (QoL). Methods: In this randomized triple-blind trial, adult IBS volunteers who were recruited...
3.
Kostamo P, Veijola L, Oksanen A, Sarna S, Rautelin H
Int J Antimicrob Agents
. 2010 Nov;
37(1):22-5.
PMID: 21084175
The antimicrobial susceptibility of Helicobacter pylori is an important predictor of the success of eradication therapy. To evaluate recent changes in primary antimicrobial resistance of H. pylori isolated from Finnish...
4.
Veijola L, Oksanen A, Sipponen P, Rautelin H
Clin Vaccine Immunol
. 2008 Oct;
15(11):1705-10.
PMID: 18827192
The best method to diagnose Helicobacter pylori infection in different clinical situations is controversial. The aim of the study was to assess the performance of a commercial immunoblot, Helicoblot 2.1....
5.
Seppala K, Kosunen T, Veijola L, Sipponen P, Arkkila P, Rautelin H, et al.
Scand J Gastroenterol
. 2008 Jul;
43(9):1149-50.
PMID: 18609180
No abstract available.
6.
Oksanen A, Veijola L, Korudanova B, Sipponen P, Sarna S, Rautelin H
Scand J Gastroenterol
. 2008 Jul;
43(9):1044-9.
PMID: 18609178
Objective: Repeat gastroscopy is not recommended for patients without alarm symptoms and with a normal earlier gastroscopy. However, there is little information available on the consequences of this recommendation. The...
7.
Veijola L, Oksanen A, Linnala A, Sipponen P, Rautelin H
Helicobacter
. 2007 Nov;
12(6):605-8.
PMID: 18001400
Aim: The persistence of chronic inflammation in gastric mucosa and elevated Helicobacter pylori antibodies after successful eradication therapy are common findings in clinical practice. We studied their possible association with...
8.
Veijola L, Nilsson I, Halme L, Abu Al-Soud W, Makinen J, Ljungh A, et al.
Ann Med
. 2007 Sep;
39(7):554-60.
PMID: 17852032
Aim: To study the association between helicobacters and chronic liver diseases and chronic inflammatory bowel diseases. Patients And Methods: Thirty-two patients with various chronic liver diseases and 137 patients with...
9.
Veijola L, Sankila A, Rautelin H, Kosunen T, Sipponen P, Hyvarinen H, et al.
J Clin Gastroenterol
. 2006 Jul;
40(6):510-4.
PMID: 16825933
Background: All the risk factors of peptic ulcer disease are not thoroughly understood. Goals: To assess duodenal gastric metaplasia (DGM) in relation to Helicobacter pylori status and endoscopy findings with...
10.
Arkkila P, Seppala K, Farkkila M, Veijola L, Sipponen P
Scand J Gastroenterol
. 2006 Jun;
41(7):782-90.
PMID: 16785190
Objective: Whether gastric atrophy or intestinal metaplasia heals after successful treatment of Helicobacter pylori (H. pylori) infection is still a matter of controversy. The aim of this article was to...